- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Aurobindo Pharma Limited — Updates, 05-09-2025: General Updates
05-09-2025 | 06:36 pm
05-09-2025 | 06:36 pm
Aurobindo Pharma's Unit-XII received 8 procedural observations on a Form 483 following a US FDA inspection. The company anticipates no financial or operational impact, and will address the observations promptly.
No comments yet. Be the first to comment!